Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acceleron Pharma Inc (NASDAQ:XLRN)

35.92
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
23.07
Today|||52-Week Range
40.35
+40.75%
Year-to-Date
No recent news for Acceleron Pharma Inc.

Today’s Trading

Previous close35.92
Today’s open36.10
Day’s range35.39 - 36.10
Volume1,100,623
Average volume (3 months)395,213
Market cap$1.6B
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+20.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+53.46%
P/E ratioNM
Price/Sales34.40
Price/Book6.09

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...0.000.00%
RDUSRadius Health Inc0.000.00%
SGMOSangamo Therapeutics...0.000.00%
HALOHalozyme Therapeutic...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$27.8M
Annual profit (last year)-$57.0M
Net profit margin-205.30%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Habib J. Dable
Chief Financial Officer, Treasurer &
Senior VP
Kevin F. McLaughlin
Corporate headquarters
Cambridge, Massachusetts

Forecasts